Heron Therapeutics, Inc. (HRTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 216.72M |
| Enterprise Value | 328.71M |
| P/E Ratio | -2.42 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.45 |
| Price/Book Ratio | 8.9 |
| Enterprise/Revenue | 1.22 |
| Enterprise/EBITDA | -7.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.21 |
| Operating Margin | -0.07 |
| Return On Assets | -0.13 |
| Return On Equity | -11.15 |
| Revenue | 154.9M |
| Revenue/Share | 0.79 |
| Gross Profit | 113.56M |
| EBITDA | -17.88M |
| Net Income | -20.2M |
| Diluted EPS | -0.12 |
| Total Cash | 44.78M |
| Total Cash/Share | 0.24 |
| Total Debt | 141.63M |
| Total Debt/Equity | 15.5 |
| Current Ratio | 2.53 |
| Book Value Per Share | 0.05 |
| 52-Week Change | -79.69 |
| 52-Week High | 2.3 |
| 52-Week Low | 0.38 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 1.1 |
| Average Volume | 3.06M |
| Shares Outstanding | 157.94M |
| % Held by Institutions | 94.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 13, 2014 |